The Enterprise Value as of December 2025 (TTM) for Enimmune corporation (6564.TWO) is 1.36B

According to Enimmune corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 1.36B. This represents a change of -17.46% compared to the average of 1.65B of the last 4 quarters.

Enimmune corporation (6564.TWO) Historical Enterprise Value (quarterly & annually)

How has 6564.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Enimmune corporation over the last ten years is 2.09B. The current 1.36B Enterprise Value has changed 6.41% with respect to the historical average. Over the past ten years (40 quarters), 6564.TWO's Enterprise Value was at its highest in in the December 2022 quarter at 3.66B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Enimmune corporation (6564.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enimmune corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enimmune corporation (6564.TWO) Average Enterprise Value

How has 6564.TWO Enterprise Value performed in the past?

The current Enterprise Value of Enimmune corporation (6564.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Enimmune corporation (6564.TWO) Enterprise Value vs. Peers

How is 6564.TWO’s Enterprise Value compared to its peers?

Enimmune corporation’s Enterprise Value is greater than NaviFUS Corp. (1.28B), greater than GeneReach Biotechnology Corp. (1.19B), greater than Great Novel Therapeutics Biotech & Medicals (1.30B), greater than MegaPro Biomedical Co., Ltd (963.64M), greater than Abnova (Taiwan) Corporation (975.85M), greater than Bio Preventive Medicine Corp. (944.05M), greater than LabTurbo Biotech Corporation (711.50M), greater than BiOptic Inc. (1.33B), less than Lukas Biomedical Inc. (1.42B), less than GenMont Biotech Incorporation (1.62B),

Build a custom stock screener for Enimmune corporation (6564.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enimmune corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enimmune corporation (6564.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enimmune corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.